How Human Intestinal Cells Process Carotenoids
Author Information
Author(s): Gong Xiaoming, Tsai Shu-Whei, Yan Bingfang, Rubin Lewis P
Primary Institution: Department of Pediatrics, Women and Infants' Hospital of Rhode Island and Brown Medical School
Hypothesis
The study aims to identify human-specific regulatory mechanisms controlling BCMO1 gene expression.
Conclusion
The study shows that the expression of BCMO1 in human intestinal cells relies on the cooperation between PPARγ and MEF2 transcription factors.
Supporting Evidence
- The human BCMO1 promoter contains unique transcription factor-binding sites not found in the mouse.
- Mutations in MEF2 and PPAR binding sites significantly reduce BCMO1 expression.
- Co-expression of MEF2C and PPARγ leads to a six-fold increase in BCMO1 promoter activity.
Takeaway
This research found that two proteins, PPARγ and MEF2, work together to help our bodies convert a plant nutrient called beta-carotene into vitamin A.
Methodology
The study involved functional characterization of the human BCMO1 promoter in a human intestinal cell line, TC-7, using site-directed mutagenesis and luciferase reporter assays.
Limitations
The study does not directly associate the human-specific regulation of BCMO1 with specific metabolic consequences.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website